
Jens Montanana’s Datatec revenue falls to $3.6 billion in FY 2025
Datatec’s revenue dropped nearly 9% to $3.64 billion in FY2025, while net profit rose 36% as the group focused on cost discipline and strategic growth.
Datatec’s revenue dropped nearly 9% to $3.64 billion in FY2025, while net profit rose 36% as the group focused on cost discipline and strategic growth.
In just 16 days, his stake declined from $318.68 million to $308.54 million, tracking a 3.18-percent drop in Discovery’s stock.
The jump comes as investors continue to show strong interest in the company, reflecting growing optimism around Africa’s expanding digital landscape.
Over the past 16 days, the market value of his stake has increased by $34.74 million, propelling the market value of his stake above the $600-million mark.
The performance was underpinned by higher room occupancy, improved Ebitdar margins, and disciplined cost and capital management.
The recent dip is a reflection of the growing pressure facing one of South Africa’s most recognizable retail names.
The surge follows a strong rally in Discovery’s share price on the Johannesburg Stock Exchange (JSE).
Swartzberg, a top figure in South Africa’s financial services industry, owns a 3.92-percent stake in Discovery, about 25.95 million shares.
Sibanye-Stillwater narrows 2024 loss to $311 million under Neal Froneman, showing signs of recovery amid weak metal markets and operational restructuring.
This follows a strong recovery in Aspen's share price on the Johannesburg Stock Exchange (JSE).
In the past two weeks, Adrian Gore's stake has dropped by R753.34 million ($39.83 million) as Discovery's shares slide on the JSE.
The company paid out R11.5 billion ($593 million) in benefits, with wellness incentives and living benefits surpassing traditional death claims for the first time.
South African businessman Barry Swartzberg’s stake in JSE-listed Discovery has dropped by $40.1 million, falling from R5.5 billion ($283.8 million) to R4.72 billion ($243.7 million).
Despite the decline, Ravazzotti remains a key player in South Africa’s retail and manufacturing sector.
Attridge, co-founder and group chief advisor of Aspen Pharmacare, holds a 4.3-percent stake in the company.
His career—spanning executive leadership, major acquisitions, and boardroom influence—reflects a deep understanding of South Africa’s shifting economic landscape.